Why the study?
Does continuous epidural 0.2% ropivacaine improve postoperative pain, motor block, and gastrointestinal function compared to 0.2% bupivacaine in patients undergoing open hysterectomy?
Does continuous epidural 0.2% ropivacaine improve postoperative pain, motor block, and gastrointestinal function compared to 0.2% bupivacaine in patients undergoing open hysterectomy?
Continuous epidural infusion of 0.2% ropivacaine provides similar postoperative analgesia, motor block, and gastrointestinal recovery compared to 0.2% bupivacaine after open hysterectomy.
Answers are grounded in this paper and cite their sources.
Equivalence supports interchangeable epidural use of either agent after open hysterectomy; reinforces consensus on comparable analgesia and recovery.
We have investigated the effect of 24-h postoperative continuous epidural infusion of 0.2% ropivacaine or 0.2% bupivacaine 8 ml h-1 on pain, request for supplementary analgesics, motor block and gastrointestinal function, in a double-blind, randomized study in 60 patients undergoing open hysterectomy. There were no significant differences between groups in pain, number of patients requesting supplementary analgesics, motor block, ability to walk or time to first flatus or stool. In the subgroup of patients who received supplementary analgesics, patients in the ropivacaine group received significantly more ketorolac than patients in the bupivacaine group. Time to discharge from hospital was similar with ropivacaine and bupivacaine.
No takes yet. Share an insight, caveat, or question.
Jørgensen et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: